[KSCI] Korea Science Citation Index Service

Development and Research into Functional Foods from Hydrolyzed Whey Protein Powder with Sialic Acid as Its Index Component - III. Bacterial Reverse Mutation Testing of Hydrolyzed Whey Protein Powder Containing Normal Concentration of Sialic Acid (7%) with Enzyme Separation Method -

Kim, Hee-Kyong (HANILBIOMED Co.)
Noh, Hye-Ji (MEDINUTROL Co.)
Cho, Hyang-Hyun (HANILBIOMED Co.)
Koh, Hong Bum (College of Veterinary Medicine, Chonnam National University)

Publication Information

Journal of Dairy Science and Biotechnology / v.34, no.2, 2016 , pp. 137-144 More about this Journal

Abstract

The ultimate research goal of the current study was a development of hydrolyzed whey protein powder (7%-GNANA) manufactured with normal content of sialic acid, a marker compound, that is naturally occurring at 7% concentration in GMP obtained from the milk protein. GMP is a safe food, used worldwide in infant and baby foods, etc. The test substance was prepared using (7% sialic acid containing) GMP as a raw material, and then using alcalase, an enzyme approved as a food additive, after separation of sialic acid with 100% efficiency and 7%-GNANA (containing 7% sialic acid and protein; product name: HELICOBACTROL-7) provided by MEDINUTROL Inc. (Korea). Bacterial reverse mutation (Ames) test was conducted in accordance with GLP Guideline using the test substance specified above. To identify its mutagenic potential against microorganisms, histidine auxotrophic strains of Salmonella Typhimurium, TA98, TA100, TA1535, and TA1537, and tryptophan auxotrophic strain of Escherichia coli, WP2uvrA, were used. The bacterial reverse mutation (Ames) test was performed by dividing the test substances into five different concentration groups (0, 61.7, 185, 556, 1,670, $5,000{\mu}g/plate$ ). Results of this experiment did not reveal repetitive increase of colony generating values or positive criteria for reverse mutagenicity for any concentration of test substances in any of the five strains, regardless of the presence of a metabolic activation system, and no dose-dependency was identified. In conclusion, the safety of 7%-GNANA test substance was verified by bacterial reverse mutation test conducted before registration of 7%-GNANA as a food additive.

Keywords

glycomacropeptide; sialic acid; bacterial reverse mutation test; base substitution; frameshift;

Citations & Related Records

Reference

1	Gorog, P. and Kovacs, I. B. 1978. Anti-inflammatory effect of sialic acid. Agents and Actions 8:543-545. DOI
2	Iijima, R., Takahashi, H., Namme, R., Ikegami, S. and Yamazaki, M. (2004). Novel biological funtion of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger. FEBS Letters 561:163-166. DOI
3	Kelleher, S. L., Chatterton, D., Nielsen, K. and Lonnerdal, B. 2003. Glycomacropeptide and ${\alpha}$ -lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys. Am. J. Clin. Nutr. 77:1261-1268. DOI
4	Korea Food and Drug Administration(KFDA). 2014. The above study was conducted in accordance with the Ministry of Food and Drug Safety. KFDA Notice No. 2014-136 (Jul. 30.).
5	Korea Food and Drug Administration(KFDA). 2015. Guidelines for toxicity tests in drugs, etc. KFDA Notice No. 2014-67 (Feb. 12).
6	Aimutis, W. R. 2004. Bioactive properties of milk proteins with particular focus on anticariogenesis. J. Nutr. 134:989-995. DOI
7	Brody, E. P. 2000. Biological activities of bovine glyco-macropeptide. British Journal of Nutrition 84:S39-S46.
8	Maron, D. M. and Ames, B. N. 1983. Revised methods for the Salmonella mutagenicity test. Mutation Res. 113:173-215. DOI
9	Marshall, S. C. 1991. Casein macropeptide from whey. A new product opportunity. Food Res. Quar. 15:86-91.
10	Moon, Y.-I., Lee, W. and Oh, S. 2005. Glycomacropeptide hydrolysed from bovine ${\kappa}$ -casein: II. Chromatographic changes of ${\kappa}$ -casein macropeptide as related to trichloroacetic acid concentration. Korean J. Food Sci. Ani. Resour. 25: 478-482.
11	Organization for Economic Cooperation and Development. 1993. OECD guideline for the testing of chemicals, 'Guidelines for the management of non-clinical studies' OECD Test guidelines (No. 473) and GLP Center Standard Operating Procedures.
12	Organization for Economic Cooperation and Development. 2008. OECD Guidelines 408 for the testing of chemicals: Repeated Dose 90-day Oral Toxicity Study in Rodents.
13	Springer-Verlag, R. S. 1984. Sialic acids: Chemistry, metabolism and function. Carbohydrate Research 129:c5-c7. DOI
14	Takahashi, N., Asakawa, S., Shunichi, D. and Tadashi, I. 1992. Hypoallergenic nutritive composition. Freench Pat. Appl. Fr. 2667 850A1.
15	Wang, B. 2009. Sialic acid is and essential nutrient for brain development and cognition. Annu. Rev. Nutr. 29: 177-222. DOI
16	Wang, B. and Brand-Miller, J. 2003. The role and potential of silaic acid in human nutrition. European Journal of Clinical Nutrition 57:1351-1369. DOI
17	Wang, B., Brand-Miller, J., McVeagh, P. and Petocz, P. 2001. Concentration and distribution of sialic acid in human milk and infant $formulas^{1-3}$ . Am. J. Clin. Nutr. 74:510-515. DOI
18	Yoon, Y. C., Cho, J. K., Song, C. H., Lee, S. and Chung, C. I. 2000. Purification of the glycomacropeptide from cheese whey. Korean J. Food Sci. Ani. Resour. 20:159-165.
19	Wang, B., Yu, B., Karim, M., Hu, H., Sun, Y., McGreevy, P., Petocz, P., Held, S. and Brand-Miller, J. 2007. Dietary sialic acid supplementation improves learning and memory in $piglets^{1-3}$ . Am. J. Clin. Nutr. 85:561-569. DOI